CIMZIA is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis; CIMZIA is indicated for the treatment of . drug interactions. o Cimzia is indicated for reducing signs and symptoms of Crohn’s disease and modifying anti-rheumatic drug (DMARD). 3. Cimzia [package insert]. Smyrna. Medscape – Rheumatoid arthritis and Crohn disease dosing for Cimzia ( certolizumab pegol), frequency-based adverse effects, comprehensive interactions.

Author: Mezijind Nek
Country: Mali
Language: English (Spanish)
Genre: Medical
Published (Last): 15 September 2004
Pages: 190
PDF File Size: 7.93 Mb
ePub File Size: 8.55 Mb
ISBN: 214-1-17388-371-1
Downloads: 7587
Price: Free* [*Free Regsitration Required]
Uploader: Gall

Please see full Prescribing Information. It is given by injection under the skin, usually in the thigh or abdomen tummy. Active tuberculosis TBincluding reactivation of latent TB.

Leave this field blank. If an infection develops, monitor carefully and initiate appropriate therapy. Patients with rheumatoid arthritis, particularly those with cijzia active disease, are at a higher risk of lymphoma than the general population. Cimzia must not be used in patients with active tuberculosis, other severe infections, or moderate to severe heart failure inability of the heart to pump enough blood around the body.

Dosing Information | CIMZIA® (certolizumab pegol)

Certolizumab pegol for the treatment of chronic plaque psoriasis: Rheumatoid arthritis Cimzia, in combination with methotrexate MTXis indicated for: Similar results were seen in a study with patients who had not adequately responded to other medicines such as methotrexate. Discontinue treatment if symptoms of a lupus-like syndrome develop. How useful was this cimiza Changes since initial authorisation of medicine List item. Cimzia has been shown to reduce the rate of progression of joint damage as measured by X ray and to improve physical function, when given in combination with MTX.


International non-proprietary name INN or common name. For more information see the package leaflet or contact your doctor or pharmacist. Expand all Collapse all.

Dosing Information

Bacterial, viral, and other infections due to opportunistic pathogens, including Legionella and Listeria. In the treatment of moderate to severe plaque psoriasis, Cimzia was compared with placebo in two main studies. After training, patients may inject Cimzia themselves if their doctor agrees.

inser All other trademarks and registered trademarks are the property of their respective holders. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Psoriatic arthritis Cimzia, in combination with MTX, is indicated for the treatment of active psoriatic arthritis in adults when the response to previous DMARD therapy has been inadequate.

Monitor patients closely for the development of signs and symptoms of infection during and after treatment with CIMZIA, including the possible development of TB in patients who tested negative for latent TB infection prior to initiating therapy.

Treatment with Cimzia mg every two weeks in the two studies led to In patients with active rheumatoid arthritis who had never received DMARDs, treatment with Cimzia led to sustained remission no detectable disease activity after 52 weeks of treatment. Side effects reported with Cimzia are carefully evaluated and any necessary action taken to protect patients. CIMZIA is contraindicated in patients with a history of hypersensitivity reaction to certolizumab pegol or to any of the excipients.


Consider the risks and benefits of CIMZIA treatment isert to initiating or continuing therapy in a patient with known malignancy. Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: Anatomical therapeutic chemical ATC code.

Adv Drug Deliv Rev. J Am Acad Dermatol.

We’re strengthening digital security to protect you.

The impact of PEGylation on biologic therapies. Mechanism of action of certolizumab pegol CDP Carefully consider lackage risks and benefits inserr treatment with CIMZIA prior to initiating therapy in the following patients: The studies included adults with active rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis and moderate to severe plaque psoriasis:.

Table of contents Overview Authorisation details Product information Assessment history. Skip to main content. Axial spondyloarthritis Cimzia is indicated for the treatment of adult patients with severe active axial spondyloarthritis, comprising: Minimal to no transfer of certolizumab pegol into breast milk: Exercise caution and monitor carefully.

Adults with severe active ankylosing spondylitis who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs NSAIDs. Nat Rev Drug Discov.